Maintenance of Cancer Stemness by Mir-196B-5p Contributes to Chemoresistance of Colorectal Cancer Cells Via Activating STAT3 Signaling Pathway

Dong Ren,Bihua Lin,Xin Zhang,Yao Peng,Ziyu Ye,Yan Ma,Yangfang Liang,Longbin Cao,Xiangyong Li,Ronggang Li,Lixia Sun,Qiongru Liu,Jinhua Wu,Keyuan Zhou,Jincheng Zeng
DOI: https://doi.org/10.18632/oncotarget.17971
2017-01-01
Oncotarget
Abstract:Emerging studies indicated that cancer stem cells represent a subpopulation of cells within the tumor that is responsible for chemotherapeutic resistance. However, the underlying mechanism is still not clarified yet. Here we report that miR-196b-5p is dramatically upregulated in CRC tissues and high expression of miR-196b-5p correlates with poor survival in CRC patients. Moreover, recurrent gains (amplification) contribute to the miR-196b-5p overexpression in CRC tissues. Silencing miR-196b-5p suppresses spheroids formation ability, the fraction of SP cells, expression of stem cell factors and the mitochondrial potential, and enhances the apoptosis induced by 5-fluorouracil in CRC cells; while ectopic expression of miR-196b-5p yields an opposite effect. In addition, downregulation of miR-196b-5p resensitizes CRC cells to 5-fluorouracil in vivo. Our results further demonstrate that miR-196b-5p promotes stemness and chemoresistance of CRC cells to 5-fluorouracil via targeting negative regulators SOCS1 and SOCS3 of STAT3 signaling pathway, giving rise to activation of STAT3 signaling. Interestingly, miR-196b-5p is highly enriched in the serum exosomes of patients with CRC compared to the healthy control subjects. Thus, our results unravel a novel mechanism of miR-196b-5p implicating in the maintenance of stem cell property and chemotherapeutic resistance in CRC, offering a potential rational registry of anti-miR-196b-5p combining with conventional chemotherapy against CRC.
What problem does this paper attempt to address?